March 9-11, 2010 in Atlanta, Georgia
The goal of the two and a half -day conference is to serve as the catalyst for developing a nationally recognized public health framework for promoting the health of and improving outcomes among people at risk for or affected by a non-malignant blood disorder. The conference, hosted by CDC in partnership with the American Society of Hematology, the Health Resources and Services Administration, and the National Heart, Lung and Blood Institute, will gather together public health practitioners, medical professionals, health educators, health communication specialists, health informatics specialists, researchers, policymakers, international public health colleagues, advocacy groups, public health professional organizations and associations, private sector leaders, and others involved in work related to blood disorders. For more information please go to www.blooddisordersconference.com.
In August 2008, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) held a workshop on the role of ribosomal biogenesis in disease in collaboration with the National Heart, Lung, and Blood Institute (NHLBI) and the Centers for Disease Control and Prevention. With the recent discovery of a ribosomal protein defect in some cases of Diamond-Blackfan Anemia, exploration into how the ribosomes could cause this disease, as well as others, needed to take place. This workshop reviewed what is currently known about ribosomal biogenesis and embarked on recent clinical connections of ribosomal malfunctioning and disease.
To review a summary of the meeting see, http://www3.niddk.nih.gov/fund/other/RibosomeWorkshopSummariesandFutureDirections.pdf.